Colleen Volpe Physical Therapist Medicare: Medicare Enrolled Practice Location: 8170 Rourk St, Myrtle Beach, SC 29572 Phone: 843-449-1963 |
Casey E Garavito, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4125 Dick Pond Rd, Myrtle Beach, SC 29588 Phone: 843-999-0284 |
Lindsey Veronica Hilliard, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 210 Village Center Blvd Ste 100, Myrtle Beach, SC 29579 Phone: 843-491-4937 Fax: 843-491-4938 |
Ryan Grzeschik Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7955 N Kings Hwy Ste 330, Myrtle Beach, SC 29572 Phone: 843-945-1825 |
Dr. Cassie Lee Woodrow, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 198 Village Center Blvd, Myrtle Beach, SC 29579 Phone: 843-652-8273 Fax: 843-652-8274 |
Dr. Michael Gerard Brophy, DPT Physical Therapist - Geriatrics Medicare: Accepting Medicare Assignments Practice Location: 4404 Boxwood St, Myrtle Beach, SC 29577 Phone: 864-542-7709 |
News Archive
Mobile Aspects announced today that the University of Michigan Health System has signed an agreement to expand the use of its tissue tracking solution into the Operating Room at the University of Michigan C.S. Mott Children's Hospital. The solution, called iRISecureā¢, uses the unique characteristics of radio frequency identification (RFID) technology to automate clinical workflow associated with tissue tracking.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have identified and characterized mutated forms of the gene that encodes BCR-ABL, the unregulated enzyme driving the blood cancer chronic myeloid leukemia (CML).
While newly published research confirms that under laboratory circumstances prion-protein can be absorbed across the gut, it also shows that this is unlikely to occur in real life.
Pearl Therapeutics Inc. announced plans to make 11 presentations at upcoming medical meetings to report clinical and product development information pertaining to PT003 (GFF MDI), a proprietary, fixed-dose combination of glycopyrrolate (GP), a long-acting muscarinic antagonist (LAMA) and formoterol fumarate (FF), a long-acting beta-2 agonist.
› Verified 7 days ago